Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

25T7-NBOMe

From Wikipedia, the free encyclopedia
Chemical compound

Pharmaceutical compound
25T7-NBOMe
Clinical data
Other names2C-T-7-NBOMe; NBOMe-2C-T-7;N-(2-Methoxybenzyl)-4-propylthio-2,5-dimethoxyphenethylamine
Drug classSerotonin5-HT2 receptoragonist;Serotonergic psychedelic;Hallucinogen
ATC code
  • None
Legal status
Legal status
Identifiers
  • 2-(2,5-dimethoxy-4-propylsulfanylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
CAS Number
PubChemCID
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC21H29NO3S
Molar mass375.53 g·mol−1
3D model (JSmol)
  • CCCSC1=C(C=C(C(=C1)OC)CCNCC2=CC=CC=C2OC)OC
  • InChI=1S/C21H29NO3S/c1-5-12-26-21-14-19(24-3)16(13-20(21)25-4)10-11-22-15-17-8-6-7-9-18(17)23-2/h6-9,13-14,22H,5,10-12,15H2,1-4H3
  • Key:CPVMNHOHOSNFOP-UHFFFAOYSA-N

25T7-NBOMe, also known as2C-T-7-NBOMe orNBOMe-2C-T-7 as well asN-(2-methoxybenzyl)-4-propylthio-2,5-dimethoxyphenethylamine, is aserotonergic psychedelic of the25-NB (NBOMe) family. It is the NBOMeanalogue of2C-T-7. The compound has been sold as adesigner drug.[2][3][4][5][6]

Use and effects

[edit]

The activedose range androute of 25T7-NBOMe do not appear to have been described.[7]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Pharmacology

[edit]

Pharmacodynamics

[edit]
25T7-NBOMe activities
TargetAffinity (Ki, nM)
5-HT1A1,800
5-HT1B1,902
5-HT1D2,176
5-HT1END
5-HT1FND
5-HT2A0.68–1.1 (Ki)
7.42–260 (EC50Tooltip half-maximal effective concentration)
41–173% (EmaxTooltip maximal efficacy)
5-HT2B2.3 (Ki)
310 (EC50)
14% (
Emax)
5-HT2C6.4 (Ki)
19.1 (EC50)
95% (
Emax)
5-HT3ND
5-HT4ND
5-HT5AND
5-HT668.8
5-HT7ND
α1A340
α1B,α1DND
α2A360
α2B,α2CND
β1β3ND
D14,100
D21,000
D31,400
D4,D5ND
H11,200
H2H4ND
M1M5ND
I1ND
σ1,σ2ND
ORsND
TAAR1Tooltip Trace amine-associated receptor 11,000 (Ki) (mouse)
88–90 (Ki) (rat)
2,100 (EC50) (mouse)
550 (
EC50) (rat)
>10,000 (
EC50) (human)
68% (
Emax) (mouse)
52% (
Emax) (rat)
SERTTooltip Serotonin transporter3,200 (Ki)
17,000 (IC50Tooltip half-maximal inhibitory concentration)
ND (EC50)
NETTooltip Norepinephrine transporter3,700 (Ki)
34,000 (IC50)
ND (EC50)
DATTooltip Dopamine transporter4,800 (Ki)
55,000 (IC50)
ND (EC50)
Notes: The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified.Refs:[8][9][10][2][3][11]

25T7-NBOMe acts as a highlypotent andselectiveagonist of theserotonin5-HT2 receptors.[2] Itsaffinities and activities at a variety of otherreceptors andtransporters have also been described.[2]

History

[edit]

25T7-NBOMe was first described in thescientific literature by 2012.[12]

Society and culture

[edit]

Legal status

[edit]

Canada

[edit]

25T7-NBOMe is acontrolled substance inCanada under phenethylamine blanket-ban language.[13]

See also

[edit]

References

[edit]
  1. ^Anvisa (2023-07-24)."RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese).Diário Oficial da União (published 2023-07-25).Archived from the original on 2023-08-27. Retrieved2023-08-27.
  2. ^abcdRickli A, Luethi D, Reinisch J, Buchy D, Hoener MC, Liechti ME (December 2015)."Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)"(PDF).Neuropharmacology.99:546–553.doi:10.1016/j.neuropharm.2015.08.034.PMID 26318099.
  3. ^abPottie E, Poulie CB, Simon IA, Harpsøe K, D'Andrea L, Komarov IV, et al. (August 2023)."Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT2A Receptor Agonists".ACS Chemical Neuroscience.14 (15):2727–2742.doi:10.1021/acschemneuro.3c00267.PMC 10401645.PMID 37474114.
  4. ^Botch-Jones S, Foss J, Barajas D, Kero F, Young C, Weisenseel J (October 2016). "The detection of NBOMe designer drugs on blotter paper by high resolution time-of-flight mass spectrometry (TOFMS) with and without chromatography".Forensic Science International.267:89–95.doi:10.1016/j.forsciint.2016.08.008.PMID 27572638.
  5. ^Grumann C, Auwärter V (February 2018). "Separation of positional isomers of nine 2-phenethylamine-derived designer drugs by liquid chromatography-tandem mass spectrometry".Drug Testing and Analysis.10 (7):1184–1191.doi:10.1002/dta.2371.PMID 29455470.
  6. ^Fan SY, Zang CZ, Shih PH, Ko YC, Hsu YH, Lin MC, et al. (August 2021). "Simultaneous LC-MS/MS screening for multiple phenethylamine-type conventional drugs and new psychoactive substances in urine".Forensic Science International.325 110884.doi:10.1016/j.forsciint.2021.110884.PMID 34245937.S2CID 235791505.
  7. ^Luethi D, Liechti ME (October 2018)."Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics".Int J Neuropsychopharmacol.21 (10):926–931.doi:10.1093/ijnp/pyy047.PMC 6165951.PMID 29850881.
  8. ^"Ki values for 25T7-NBOMe".Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill. 15 July 2025. Retrieved15 July 2025.
  9. ^Hansen M (2010-12-16).Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain (Ph.D. thesis). University of Copenhagen.doi:10.13140/RG.2.2.33671.14245.
  10. ^Hansen M, Phonekeo K, Paine JS, Leth-Petersen S, Begtrup M, Bräuner-Osborne H, et al. (March 2014)."Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists".ACS Chemical Neuroscience.5 (3):243–249.doi:10.1021/cn400216u.PMC 3963123.PMID 24397362.
  11. ^Simmler LD, Buchy D, Chaboz S, Hoener MC, Liechti ME (April 2016)."In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1"(PDF).J Pharmacol Exp Ther.357 (1):134–144.doi:10.1124/jpet.115.229765.PMID 26791601. Archived fromthe original(PDF) on 2025-05-09.
  12. ^Casale JF, Hays PA (2012)."Characterization of eleven 2, 5-dimethoxy-N-(2-methoxybenzyl) phenethylamine (NBOMe) derivatives and differentiation from their 3-and 4-methoxybenzyl analogues—part I."(PDF).Microgram Journal.9 (2):84–109.
  13. ^"Controlled Drugs and Substances Act".Department of Justice Canada. Retrieved19 January 2026.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
TAAR1Tooltip Trace amine-associated receptor 1
Agonists
Endogenous
Exogenous
Antagonists
Inverse agonists
TAAR5Tooltip Trace amine-associated receptor 5
Agonists
Inverse agonists
Notes: (1) TAAR1 activity of ligands varies significantly between species. Some agents that are TAAR1 ligands in some species are not in other species. This navbox includes all TAAR1 ligands regardless of species. (2) See the individual pages for references, as well as theList of trace amines,TAAR, andTAAR1 pages.
See also:Receptor/signaling modulators
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=25T7-NBOMe&oldid=1338088520"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp